NEW YORK (GenomeWeb News) – Identitas and Akesogen today announced a commercial partnership they said will allow forensics investigators "to generate more comprehensive leads from DNA samples than had previously been possible."

The companies have entered into a licensing deal providing Akesogen access to Identitas' ISAS software, which interrogates SNPs for a profile that describes the physical appearance of an individual. Akesogen will offer an end-to-end genetic analysis package powered by ISAS.

Financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.

An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.

Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.

US lawmakers want to develop a new incarnation of the National Children's Study, ScienceInsider reports.